Intratumoral heterogeneity as a predictive biomarker in anti-PD-(L)1 therapies for non-small cell lung cancer.

ABSTRACT:

SUBMITTER: Fang W 

PROVIDER: S-EPMC7901210 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature